NR546 MIDTERM PSYCHOPHARMACOLOGY EXAM 200
QUESTIONS AND CORRECT ANSWER WITH RATIONALE
ALREADY GRADED A+
Each entry presents a unique clinical scenario, drug mechanism, side effect
profile, or pharmacogenetic principle. While core topics like SSRIs,
antipsychotic side effects, CYP450 interactions, and mood stabilizers recur,
they are tested through different patient presentations, distinct drug
comparisons, and varying answer choices. For instance, EPS is covered in
multiple questions but each addresses a different aspect—risk factors,
treatment, or specific medications. Every question is structurally and
contextually distinct, ensuring comprehensive and non-redundant coverage of
the NR546 midterm blueprint.
1. A drug that acts as an inverse agonist at a receptor will produce which of the
following effects?
a) The same effect as a neutral antagonist
b) Stabilization of the receptor in its inactive state, reducing constitutive activity
c) Blockade of the receptor without affecting baseline activity
d) Activation of the receptor to a greater degree than a full agonist
Correct Answer: b) Stabilization of the receptor in its inactive state, reducing
constitutive activity
Rationale: An inverse agonist stabilizes a receptor in its inactive conformation,
reducing the baseline (constitutive) activity of the receptor. A neutral antagonist
simply blocks agonist binding without affecting constitutive activity. A full agonist
activates the receptor to produce a maximal response .
2. The therapeutic effect of selective serotonin reuptake inhibitors (SSRIs) is
primarily mediated by which mechanism?
a) Upregulation of postsynaptic 5-HT2A receptors
b) Downregulation of presynaptic autoreceptors and desensitization
c) Immediate increase in synaptic serotonin
d) Antagonism of norepinephrine transporters
,Correct Answer: b) Downregulation of presynaptic autoreceptors and
desensitization
Rationale: While SSRIs immediately increase synaptic serotonin, the therapeutic
lag (2–4 weeks) is due to the time required for presynaptic 5-HT1A autoreceptors
to desensitize, allowing for sustained serotonergic transmission. This delayed
effect explains why patients do not experience immediate symptom relief .
3. A drug with high affinity for the sigma-1 receptor is most likely to be used for
which purpose?
a) Antipsychotic effects
b) Cognitive enhancement in depression
c) Induction of anesthesia
d) Treatment of narcolepsy
Correct Answer: b) Cognitive enhancement in depression
Rationale: Sigma-1 receptor agonism is associated with neuroplasticity,
neuroprotection, and cognitive enhancement. Fluvoxamine is an SSRI with high
sigma-1 affinity, and this property is thought to contribute to its cognitive benefits
in depression treatment .
4. Which pharmacokinetic parameter represents the time required for a drug to
reach its maximum concentration in the plasma?
a) Half-life (t½)
b) Area under the curve (AUC)
c) Time to peak (Tmax)
d) Volume of distribution (Vd)
Correct Answer: c) Time to peak (Tmax)
Rationale: Tmax is the time at which the maximum serum concentration (Cmax) is
achieved. This parameter is primarily influenced by the drug's absorption rate and
is important for determining onset of action and dosing intervals .
5. A patient who is a poor metabolizer (PM) of CYP2D6 substrates is prescribed a
drug metabolized by this enzyme. What is the most likely outcome?
a) Reduced drug efficacy
b) Increased risk of adverse effects at standard doses
c) Faster clearance of the drug
d) Reduced half-life
Correct Answer: b) Increased risk of adverse effects at standard doses
Rationale: Poor metabolizers have reduced or absent CYP2D6 enzyme activity,
leading to higher serum concentrations and prolonged half-life of CYP2D6
,substrates. This increases the risk of dose-dependent adverse effects and may
require dose adjustment .
6. Which of the following best describes pharmacodynamics?
a) The study of drug absorption, distribution, metabolism, and excretion
b) The study of what the drug does to the body, including receptor binding and
effects
c) The genetic variations that affect drug metabolism
d) The process of drug formulation and delivery
Correct Answer: b) The study of what the drug does to the body, including receptor
binding and effects
Rationale: Pharmacodynamics refers to the biochemical and physiological effects
of drugs on the body, including receptor interactions, signal transduction, and
dose-response relationships. Pharmacokinetics, in contrast, describes what the
body does to the drug .
7. A patient's family member asks why genetic testing is being considered before
starting an antidepressant. The PMHNP explains that pharmacogenomic testing is
used to:
a) Diagnose the specific type of depression
b) Determine if the patient will respond to medication based on genetic variations
c) Identify the exact dose needed for therapeutic effect
d) Replace the need for clinical assessment
Correct Answer: b) Determine if the patient will respond to medication based on
genetic variations
Rationale: Pharmacogenomic testing identifies genetic variations that affect drug
metabolism, efficacy, and adverse effect risk. It can guide medication selection but
does not replace clinical assessment or definitively determine exact dosing .
8. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take prescribed medication. This reflects which type of
factor contributing to nonadherence?
a) Client factors
b) Clinician factors
c) Structural factors
d) Environmental factors
Correct Answer: c) Structural factors
Rationale: Structural factors include the organization and delivery of healthcare,
including how information is presented to patients. The patient's denial and refusal
, based on the stigma associated with the diagnosis and how it was communicated
represent a structural barrier to adherence .
9. A patient taking a psychotropic medication has a seizure. Which medication is
most likely responsible if it lowers the seizure threshold?
a) Bupropion
b) Sertraline
c) Fluoxetine
d) Venlafaxine
Correct Answer: a) Bupropion
Rationale: Bupropion is known to lower the seizure threshold in a dose-dependent
manner. The risk is increased with higher doses, rapid titration, and in patients with
predisposing conditions. Seizure risk is a key consideration when prescribing
bupropion .
10. A PMHNP is educating a patient about a newly prescribed SSRI. Which
statement about informed consent is most accurate?
a) Informed consent is only required for invasive procedures
b) Clients have the right to receive enough information to make decisions about
their treatment
c) Informed consent can be waived for psychiatric medications
d) The provider does not need to discuss side effects if the medication is FDA-
approved
Correct Answer: b) Clients have the right to receive enough information to make
decisions about their treatment
Rationale: Informed consent is a fundamental ethical and legal requirement in
healthcare. Clients must be provided with adequate information about the proposed
treatment, including benefits, risks, alternatives, and potential side effects, to make
an autonomous decision .
11. A 44-year-old patient with schizophrenia has comorbid alcohol use disorder.
Alcohol affects GABA and glutamate in the ventral tegmental area by which
mechanism?
a) Increasing GABA and decreasing glutamate
b) Increasing both GABA and glutamate
c) Decreasing GABA and increasing glutamate
d) Decreasing both GABA and glutamate
Correct Answer: a) Increasing GABA and decreasing glutamate
Rationale: Alcohol enhances inhibitory GABA neurotransmission while
suppressing excitatory glutamate transmission in the VTA. This combination
QUESTIONS AND CORRECT ANSWER WITH RATIONALE
ALREADY GRADED A+
Each entry presents a unique clinical scenario, drug mechanism, side effect
profile, or pharmacogenetic principle. While core topics like SSRIs,
antipsychotic side effects, CYP450 interactions, and mood stabilizers recur,
they are tested through different patient presentations, distinct drug
comparisons, and varying answer choices. For instance, EPS is covered in
multiple questions but each addresses a different aspect—risk factors,
treatment, or specific medications. Every question is structurally and
contextually distinct, ensuring comprehensive and non-redundant coverage of
the NR546 midterm blueprint.
1. A drug that acts as an inverse agonist at a receptor will produce which of the
following effects?
a) The same effect as a neutral antagonist
b) Stabilization of the receptor in its inactive state, reducing constitutive activity
c) Blockade of the receptor without affecting baseline activity
d) Activation of the receptor to a greater degree than a full agonist
Correct Answer: b) Stabilization of the receptor in its inactive state, reducing
constitutive activity
Rationale: An inverse agonist stabilizes a receptor in its inactive conformation,
reducing the baseline (constitutive) activity of the receptor. A neutral antagonist
simply blocks agonist binding without affecting constitutive activity. A full agonist
activates the receptor to produce a maximal response .
2. The therapeutic effect of selective serotonin reuptake inhibitors (SSRIs) is
primarily mediated by which mechanism?
a) Upregulation of postsynaptic 5-HT2A receptors
b) Downregulation of presynaptic autoreceptors and desensitization
c) Immediate increase in synaptic serotonin
d) Antagonism of norepinephrine transporters
,Correct Answer: b) Downregulation of presynaptic autoreceptors and
desensitization
Rationale: While SSRIs immediately increase synaptic serotonin, the therapeutic
lag (2–4 weeks) is due to the time required for presynaptic 5-HT1A autoreceptors
to desensitize, allowing for sustained serotonergic transmission. This delayed
effect explains why patients do not experience immediate symptom relief .
3. A drug with high affinity for the sigma-1 receptor is most likely to be used for
which purpose?
a) Antipsychotic effects
b) Cognitive enhancement in depression
c) Induction of anesthesia
d) Treatment of narcolepsy
Correct Answer: b) Cognitive enhancement in depression
Rationale: Sigma-1 receptor agonism is associated with neuroplasticity,
neuroprotection, and cognitive enhancement. Fluvoxamine is an SSRI with high
sigma-1 affinity, and this property is thought to contribute to its cognitive benefits
in depression treatment .
4. Which pharmacokinetic parameter represents the time required for a drug to
reach its maximum concentration in the plasma?
a) Half-life (t½)
b) Area under the curve (AUC)
c) Time to peak (Tmax)
d) Volume of distribution (Vd)
Correct Answer: c) Time to peak (Tmax)
Rationale: Tmax is the time at which the maximum serum concentration (Cmax) is
achieved. This parameter is primarily influenced by the drug's absorption rate and
is important for determining onset of action and dosing intervals .
5. A patient who is a poor metabolizer (PM) of CYP2D6 substrates is prescribed a
drug metabolized by this enzyme. What is the most likely outcome?
a) Reduced drug efficacy
b) Increased risk of adverse effects at standard doses
c) Faster clearance of the drug
d) Reduced half-life
Correct Answer: b) Increased risk of adverse effects at standard doses
Rationale: Poor metabolizers have reduced or absent CYP2D6 enzyme activity,
leading to higher serum concentrations and prolonged half-life of CYP2D6
,substrates. This increases the risk of dose-dependent adverse effects and may
require dose adjustment .
6. Which of the following best describes pharmacodynamics?
a) The study of drug absorption, distribution, metabolism, and excretion
b) The study of what the drug does to the body, including receptor binding and
effects
c) The genetic variations that affect drug metabolism
d) The process of drug formulation and delivery
Correct Answer: b) The study of what the drug does to the body, including receptor
binding and effects
Rationale: Pharmacodynamics refers to the biochemical and physiological effects
of drugs on the body, including receptor interactions, signal transduction, and
dose-response relationships. Pharmacokinetics, in contrast, describes what the
body does to the drug .
7. A patient's family member asks why genetic testing is being considered before
starting an antidepressant. The PMHNP explains that pharmacogenomic testing is
used to:
a) Diagnose the specific type of depression
b) Determine if the patient will respond to medication based on genetic variations
c) Identify the exact dose needed for therapeutic effect
d) Replace the need for clinical assessment
Correct Answer: b) Determine if the patient will respond to medication based on
genetic variations
Rationale: Pharmacogenomic testing identifies genetic variations that affect drug
metabolism, efficacy, and adverse effect risk. It can guide medication selection but
does not replace clinical assessment or definitively determine exact dosing .
8. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take prescribed medication. This reflects which type of
factor contributing to nonadherence?
a) Client factors
b) Clinician factors
c) Structural factors
d) Environmental factors
Correct Answer: c) Structural factors
Rationale: Structural factors include the organization and delivery of healthcare,
including how information is presented to patients. The patient's denial and refusal
, based on the stigma associated with the diagnosis and how it was communicated
represent a structural barrier to adherence .
9. A patient taking a psychotropic medication has a seizure. Which medication is
most likely responsible if it lowers the seizure threshold?
a) Bupropion
b) Sertraline
c) Fluoxetine
d) Venlafaxine
Correct Answer: a) Bupropion
Rationale: Bupropion is known to lower the seizure threshold in a dose-dependent
manner. The risk is increased with higher doses, rapid titration, and in patients with
predisposing conditions. Seizure risk is a key consideration when prescribing
bupropion .
10. A PMHNP is educating a patient about a newly prescribed SSRI. Which
statement about informed consent is most accurate?
a) Informed consent is only required for invasive procedures
b) Clients have the right to receive enough information to make decisions about
their treatment
c) Informed consent can be waived for psychiatric medications
d) The provider does not need to discuss side effects if the medication is FDA-
approved
Correct Answer: b) Clients have the right to receive enough information to make
decisions about their treatment
Rationale: Informed consent is a fundamental ethical and legal requirement in
healthcare. Clients must be provided with adequate information about the proposed
treatment, including benefits, risks, alternatives, and potential side effects, to make
an autonomous decision .
11. A 44-year-old patient with schizophrenia has comorbid alcohol use disorder.
Alcohol affects GABA and glutamate in the ventral tegmental area by which
mechanism?
a) Increasing GABA and decreasing glutamate
b) Increasing both GABA and glutamate
c) Decreasing GABA and increasing glutamate
d) Decreasing both GABA and glutamate
Correct Answer: a) Increasing GABA and decreasing glutamate
Rationale: Alcohol enhances inhibitory GABA neurotransmission while
suppressing excitatory glutamate transmission in the VTA. This combination
